학술논문
High Efficacy and Particular Safety Profile of Imatinib Mesylate (Glivec®) in Elderly Patients with CML in Chronic Phase: Results of the AFR04 Prospective Study.
Document Type
Abstract
Author
Source
In Blood 16 November 2007 110(11):1039-1039
Subject
Language
ISSN
0006-4971